Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × merestinib × Tumor-Agnostic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 Lymphoid 2 Tumor-Agnostic 1 Dermatologic 1 Breast 1

Conditions

Interventions

Paclitaxel 52 Carboplatin 48 Surveys and Questionnaires 43 Gemcitabine 41 Bevacizumab 35 Docetaxel 30 pembrolizumab 28 Nivolumab 25 Cisplatin 24 Fluorouracil 23 Erlotinib Hydrochloride 21 Capecitabine 21 Irinotecan 20 Sorafenib 19 Leucovorin 18 Pemetrexed 16 Oxaliplatin 16 Afatinib 16 Trastuzumab 15 Radiotherapy 15 regorafenib 14 olaparib 13 Ipilimumab 13 Blood Specimen Collection 13 Sunitinib 12 Interviews as Topic 12 Cetuximab 12 130-nm albumin-bound paclitaxel 12 Standard of Care 11 eribulin 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01285037 2018-02-20

A Study of LY2801653 in Advanced Cancer

Eli Lilly and Company

Phase 1 Completed

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡